Dec 2022 | Dec 2021 | ||
---|---|---|---|
Total Revenue | |||
Cost of Revenue | |||
Gross Profit | |||
Gross Profit Margin (%) | |||
R&D Expense | |||
SG&A Expense | |||
Total Operating Expenses | |||
Operating Income or Loss | |||
Operating Margin (%) | |||
Interest Expense | |||
Total Other Income/Expenses | |||
Income Before Tax | |||
Income Tax Expense | |||
Income from Continuing Ops. | |||
Net Income | |||
Net Profit Margin (%) | |||
Net Income Available to Common Shareholders | |||
Basic EPS | |||
Diluted EPS | |||
Basic Average Shares | |||
Diluted Average Shares |
Mar 2023 | Dec 2022 | Dec 2021 | ||
---|---|---|---|---|
Total Revenue | ||||
Cost of Revenue | ||||
Gross Profit | ||||
Gross Profit Margin (%) | ||||
R&D Expense | ||||
SG&A Expense | ||||
Total Operating Expenses | ||||
Operating Income or Loss | ||||
Operating Margin (%) | ||||
Interest Expense | ||||
Total Other Income/Expenses | ||||
Income Before Tax | ||||
Income Tax Expense | ||||
Income from Continuing Ops. | ||||
Net Income | ||||
Net Profit Margin (%) | ||||
Net Income Available to Common Shareholders | ||||
Basic EPS | ||||
Diluted EPS | ||||
Basic Average Shares | ||||
Diluted Average Shares |
Dec 2022 | Dec 2021 | ||
---|---|---|---|
Current Assets | |||
Cash & Cash Equivalents | |||
Marketable Securities | |||
Receivables | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Non-Current Assets | |||
Marketable Securities | |||
PPE Net | |||
Intangibles inc. Goodwill | |||
Other Non-Current Assets | |||
Total Non-Current Assets | |||
Total Assets | |||
Current Liabilities | |||
Accounts Payable | |||
Deferred Revenues | |||
Debt, Current | |||
Accrued Liabilities | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Non-Current Liabilities | |||
Deferred Revenues | |||
Debt, Non-Current | |||
Other Non-Current Liabilities | |||
Total Non-Current Liabilities | |||
Total Liabilities | |||
Shareholders' Equity | |||
Common Stock | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Other Shareholders' Equity | |||
Total Shareholders' Equity | |||
Total Liabilities & Shareholders' Equity |
Mar 2023 | Dec 2022 | Dec 2021 | ||
---|---|---|---|---|
Current Assets | ||||
Cash & Cash Equivalents | ||||
Marketable Securities | ||||
Receivables | ||||
Inventories | ||||
Other Current Assets | ||||
Total Current Assets | ||||
Non-Current Assets | ||||
Marketable Securities | ||||
PPE Net | ||||
Intangibles inc. Goodwill | ||||
Other Non-Current Assets | ||||
Total Non-Current Assets | ||||
Total Assets | ||||
Current Liabilities | ||||
Accounts Payable | ||||
Deferred Revenues | ||||
Debt, Current | ||||
Accrued Liabilities | ||||
Other Current Liabilities | ||||
Total Current Liabilities | ||||
Non-Current Liabilities | ||||
Deferred Revenues | ||||
Debt, Non-Current | ||||
Other Non-Current Liabilities | ||||
Total Non-Current Liabilities | ||||
Total Liabilities | ||||
Shareholders' Equity | ||||
Common Stock | ||||
Additional Paid-In Capital | ||||
Retained Earnings | ||||
Other Shareholders' Equity | ||||
Total Shareholders' Equity | ||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Dec 2021 | ||
---|---|---|---|
Cash Flows from Operating Activities | |||
Net Income | |||
Depreciation & Amortization | |||
Deferred Income Taxes | |||
Stock Based Compensation | |||
Accounts Receivable | |||
Inventory | |||
Accounts Payable | |||
Deferred Revenue | |||
Other Non-Cash | |||
Operating Cash Flow | |||
Cash Flows from Investing Activities | |||
PPE Investments | |||
Net Acquisitions | |||
Purchase of Investments | |||
Sale of Investments | |||
Other Investing Activity | |||
Investing Cash Flow | |||
Cash Flows from Financing Activities | |||
Debt Issued | |||
Proceeds from Debt Repayment | |||
Debt Repayment | |||
Proceeds from Sale of Equity | |||
Equity Repurchased | |||
Dividend Paid | |||
Other Financing Activity | |||
Financing Cash Flow | |||
Cash Position | |||
Beginning Cash Position | |||
End Cash Position | |||
Change in Cash | |||
Free Cash Flow | |||
Operating Cash Flow | |||
Capital Expenditure | |||
Free Cash Flow |
Mar 2023 | Dec 2022 | Dec 2021 | ||
---|---|---|---|---|
Cash Flows from Operating Activities | ||||
Net Income | ||||
Depreciation & Amortization | ||||
Deferred Income Taxes | ||||
Stock Based Compensation | ||||
Accounts Receivable | ||||
Inventory | ||||
Accounts Payable | ||||
Deferred Revenue | ||||
Other Non-Cash | ||||
Operating Cash Flow | ||||
Cash Flows from Investing Activities | ||||
PPE Investments | ||||
Net Acquisitions | ||||
Purchase of Investments | ||||
Sale of Investments | ||||
Other Investing Activity | ||||
Investing Cash Flow | ||||
Cash Flows from Financing Activities | ||||
Debt Issued | ||||
Proceeds from Debt Repayment | ||||
Debt Repayment | ||||
Proceeds from Sale of Equity | ||||
Equity Repurchased | ||||
Dividend Paid | ||||
Other Financing Activity | ||||
Financing Cash Flow | ||||
Cash Position | ||||
Beginning Cash Position | ||||
End Cash Position | ||||
Change in Cash | ||||
Free Cash Flow | ||||
Operating Cash Flow | ||||
Capital Expenditure | ||||
Free Cash Flow |